Yunnan Baiyao Group Co.Ltd(000538) 3 on the evening of March 25, the annual report of 2021 was released. The company achieved an operating revenue of 36.374 billion yuan in 2021, an increase of 11.09% year-on-year; The net profit attributable to shareholders of listed companies was 2.804 billion yuan, a year-on-year decrease of 49.17%. The net profit attributable to shareholders of listed companies after deducting non recurring profits and losses was 3.339 billion yuan, a year-on-year increase of 15.17%; The basic earnings per share is 2.21 yuan. The company plans to distribute cash dividends of 16 yuan (including tax) and 4 bonus shares (including tax) to all shareholders for every 10 shares.
During the reporting period, the company continued to take the establishment of the business division as the core base for production and operation. At the product level, on the basis of stabilizing the traditional advantageous stock businesses such as Yunnan Baiyao Group Co.Ltd(000538) central products ( Yunnan Baiyao Group Co.Ltd(000538) series core products), general medicine and toothpaste, the company actively explored the incremental businesses such as Panax notoginseng series oral liquid, household medical devices, personalized skin care product group, scalp health management product group and health care food. Kwai tiktok, following the new consumption trend, actively explores the O2O mode, and grasps the new track opportunities such as the pharmaceutical business, Internet healthcare, short video platform, etc., to create new scenes, educate new people, create brand unique internet marketing IP and fast growth mode, successfully touch the public crowd of jitter, fast hand, little red book, WeChat, campus and Focus Media Information Technology Co.Ltd(002027) , and the online business is increasing rapidly. In terms of business, seize the opportunity of prescription drugs flowing to the retail market, form an integrated effect in the retail pharmacy market, expand downstream channels, strengthen the construction of downstream vertical terminals, and actively expand the construction of DTP pharmacy. The main businesses of all sectors made solid progress and helped the steady implementation of the “1 + 4” second growth curve strategy.
In order to ensure the supply of raw materials for medicinal materials, Yunnan Baiyao Group Co.Ltd(000538) has created strategic varieties including Paris polyphylla, Panax notoginseng and industrial marijuana. Based on the large varieties of genuine natural medicinal resources in Yunnan, cultivate a resource system with sustainable development and technical content, build a group of branded natural medicinal resources, and build a closed-loop ecosystem tracing the whole process from planting to recycling.
In terms of medical beauty track, the company concentrates advantageous resources and actively promotes the ecological layout of medical beauty industry chain. In line with the development trend of the medical beauty industry, the company continues to make efforts in the medical beauty strategy track to provide differentiated solutions for users with different needs.
Yunnan Baiyao Group Co.Ltd(000538) said that in the future, the company will continue to focus on the established development strategy and “two wheel drive” of endogenous growth and epitaxial expansion. On the one hand, it will continue to use the existing business extension and tapping the potential to store energy for the company’s leapfrog iteration, comply with the new wave of industrial ecology and commercial digital intelligence interconnection, continuously improve the fine management and operation ability, and optimize the layout of all link channels and product echelons, All business sectors strive to achieve business collaboration, technology exchange and data sharing, and work together to build a moat of Yunnan Baiyao Group Co.Ltd(000538) ; On the other hand, we will continue to promote the introduction of innovative products at home and abroad, build a matrix of products, services and formats with market competitiveness, and build a comprehensive service capability around the medical port through the big data service platform, so as to lay the foundation for Yunnan Baiyao Group Co.Ltd(000538) transformation into a “comprehensive solution provider”.
